Entest Group, Inc.

ETNI

US29383T3005

Investment Holding Companies

Market Closed - OTC Markets Other stock markets 03:35:41 2024-04-30 pm EDT			5-day change	1st Jan Change
0.0001 ^USD	-.--%		-.--%	-.--%

2020	Entest Group, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2019	CI
2019	Entest Group, Inc. Reports Earnings Results for the Full Year Ended August 31, 2019	CI

ENTB will Change its Name to ETNI

February 14, 2018 at 12:00 am EST

Effective February 14, 2018, ENTB will change its name to ETNI.

Latest news about Entest Group, Inc.

Entest Group, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2019	20-01-21	CI
Entest Group, Inc. Reports Earnings Results for the Full Year Ended August 31, 2019	19-12-20	CI
Entest Group, Inc. Reports Earnings Results for the Third Quarter Ended May 31, 2019	19-07-15	CI
Entest Group, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2018	19-01-22	CI
Entest Group, Inc. Announces Management Changes	18-12-03	CI
Peiwen Yu completed the acquisition of 48.3% stake in Entest Group, Inc. from Regen BioPharma, Inc., Bostonia Partners, Inc, Dunhill Ross Partners, Inc., Bio-Technology Partners Business Trust, David Koos and Sherman Family Trust.	18-11-26	CI
Peiwen Yu entered into an agreement to acquire 48.3% stake in Entest Group, Inc. from Regen BioPharma, Inc., Bostonia Partners, Inc, Dunhill Ross Partners, Inc., Bio-Technology Partners Business Trust, David Koos and Sherman Family Trust for $0.33 million.	18-11-19	CI
ENTB will Change its Name to ETNI	18-02-14	CI
Entest Group, Inc. Auditor Raises 'Going Concern' Doubt	15-11-26	CI
Entest Biomedical, Inc. will Change its Ticker to ENTB from ENTB.D	15-08-21	CI
Entest Biomedical, Inc. will Change its Ticker to ENTBD from ENTB	15-07-27	CI
Christine Ichim Joins Entest BioMedical Inc. as Director of Research	14-07-16	CI
Entest Biomedical Mulls Acquisitions	13-03-06	CI
Entest Biomedical, Inc. Announces the Research Study Conducted on ImenVax(TM)	12-09-06	CI
Entest Biomedical, Inc. Restates Earnings Results for the Quarter Ended May 31, 2012	12-07-23	CI
Entest Biomedical, Inc. (OTCPK: ENTB) cancelled the acquisition of the assets of Rainbow Veterinary Hospital from Timothy Metzger.	12-07-19	CI
Entest Biomedical, Inc. and RenovoCyte, LLC Updates Progress on 10 Dog Pilot Study of "Universal Donor" Stem Cell Treatment for Canine Osteoarthritis	12-03-21	CI
Entest Biomedical, Inc. cancelled the acquisition of the assets of Titterington Veterinary Services, Inc. from Ron Titterington and Kathy Snell.	12-02-21	CI
Entest Biomedical, Inc. (OTCBB: ENTB) cancelled the acquisition of substantially all assets of Riverdale Animal Hospital, Charlinda Animal Hospital and Culver Pet Clinic from Asaf A. Qadeer.	12-02-16	CI

Entest Group, Inc., formerly Entest Biomedical, Inc., is engaged in the business combination with an unidentified company. The Company has not entered into any definitive agreement with any party, nor have there been any specific discussions with any potential business combination candidate regarding business opportunities for the Company.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
ENTEST GROUP, INC.	-.--%	4.92K
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+173.89%	6.55B
SCREAMING EAGLE ACQUISITION CORP.	+5.57%	1.05B
CHURCHILL CAPITAL CORP VII	+2.29%	983M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+20.36%	786M
ARES ACQUISITION CORPORATION II	+1.72%	664M
ALTC ACQUISITION CORP.	+40.25%	639M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
E7 GROUP	-2.15%	593M

Shell Companies

Entest Group, Inc.

Equities

ETNI

US29383T3005

Investment Holding Companies

ENTB will Change its Name to ETNI

Latest news about Entest Group, Inc.

Chart Entest Group, Inc.

Company Profile

Sector Shell Companies